Body mass index and phenotype in subjects with mild-to-moderate persistent asthma.

PubWeight™: 1.43‹?› | Rank: Top 5%

🔗 View Article (PMC 2743451)

Published in J Allergy Clin Immunol on June 01, 2009

Authors

E Rand Sutherland1, Erik B Lehman, Mihaela Teodorescu, Michael E Wechsler, National Heart, Lung, and Blood Institute's Asthma Clinical Research Network

Author Affiliations

1: National Jewish Health, Denver, CO 80206, USA. sutherlande@njhealth.org

Associated clinical trials:

Asthma Clinical Research Network (ACRN) | NCT00000577

Adiposity and Airway Inflammation in HIV-Associated Airway Disease (SHOP) | NCT02975258

Articles citing this

Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med (2013) 2.95

Vitamin D levels, lung function, and steroid response in adult asthma. Am J Respir Crit Care Med (2010) 2.40

Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity? J Allergy Clin Immunol (2011) 2.01

Spirometry and health status worsen with weight gain in obese smokers but improve in normal-weight smokers. Am J Respir Crit Care Med (2014) 1.77

A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med (2012) 1.75

Obesity and asthma: an association modified by age of asthma onset. J Allergy Clin Immunol (2011) 1.64

Cluster analysis of obesity and asthma phenotypes. PLoS One (2012) 1.56

Decreased response to inhaled steroids in overweight and obese asthmatic children. J Allergy Clin Immunol (2011) 1.49

Impact of Age and Sex on Response to Asthma Therapy. Am J Respir Crit Care Med (2015) 1.43

Human asthma phenotypes: from the clinic, to cytokines, and back again. Immunol Rev (2011) 1.29

Does obesity produce a distinct asthma phenotype? J Appl Physiol (1985) (2009) 1.21

Is there a link between obesity and asthma? Allergy Asthma Immunol Res (2014) 1.04

Being overweight increases susceptibility to indoor pollutants among urban children with asthma. J Allergy Clin Immunol (2013) 1.00

Obesity impairs apoptotic cell clearance in asthma. J Allergy Clin Immunol (2012) 0.98

Poor asthma control in obese children may be overestimated because of enhanced perception of dyspnea. J Allergy Clin Immunol Pract (2013) 0.91

Severe and uncontrolled adult asthma is associated with vitamin D insufficiency and deficiency. Respir Res (2013) 0.89

Effects of obstructive sleep apnea and gastroesophageal reflux disease on asthma control in obesity. J Asthma (2011) 0.88

Induction of IL-17A Precedes Development of Airway Hyperresponsiveness during Diet-Induced Obesity and Correlates with Complement Factor D. Front Immunol (2014) 0.88

Obesity in asthma: approaches to treatment. Curr Allergy Asthma Rep (2013) 0.84

Serum Adiponectin is Associated with Adverse Outcomes of Asthma in Men but Not in Women. Front Pharmacol (2011) 0.84

Obesity enhances Th2 inflammatory response via natural killer T cells in a murine model of allergic asthma. Int J Clin Exp Med (2015) 0.84

The asthma phenotype in the obese: distinct or otherwise? J Allergy (Cairo) (2013) 0.82

Obesity, metabolic dysregulation and oxidative stress in asthma. Biochim Biophys Acta (2011) 0.81

Surface markers of lymphocyte activation in pregnant asthmatics. Inflamm Res (2010) 0.79

Obstructive Sleep Apnea Risk, Asthma Burden, and Lower Airway Inflammation in Adults in the Severe Asthma Research Program (SARP) II. J Allergy Clin Immunol Pract (2015) 0.79

Factors associated with health-related quality of life in adults with asthma. A cross-sectional study. Multidiscip Respir Med (2012) 0.78

Advances in adult asthma diagnosis and treatment in 2009. J Allergy Clin Immunol (2010) 0.77

Atopy, but not obesity is associated with asthma severity among children with persistent asthma. J Asthma (2016) 0.77

Obesity and asthma: pathophysiology and implications for diagnosis and management in primary care. Exp Biol Med (Maywood) (2014) 0.76

Adiposity influences airway wall thickness and the asthma phenotype of HIV-associated obstructive lung disease: a cross-sectional study. BMC Pulm Med (2016) 0.75

Obstructive sleep apnoea accelerates FEV1 decline in asthmatic patients. BMC Pulm Med (2017) 0.75

Articles cited by this

Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med (2000) 8.09

Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med (2005) 7.61

Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA (2001) 6.55

Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med (1999) 6.21

Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med (2006) 5.24

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet (2004) 5.01

Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network. N Engl J Med (1996) 4.03

Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J (1999) 4.00

Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med (2007) 3.95

Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol (2002) 3.66

Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. JAMA (2001) 3.21

The epidemiology of obesity and asthma. J Allergy Clin Immunol (2005) 2.87

Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med (2007) 2.81

Clinical practice. Obstructive sleep apnea. N Engl J Med (2002) 2.67

Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ (2000) 2.54

Influence of body mass index on the response to asthma controller agents. Eur Respir J (2006) 2.41

Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med (2002) 2.24

Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol (2004) 2.22

Obesity and asthma: directions for research. Am J Respir Crit Care Med (2004) 2.21

Severe asthma: lessons from the Severe Asthma Research Program. J Allergy Clin Immunol (2007) 2.10

Body mass index in relation to adult asthma among 135,000 Norwegian men and women. Am J Epidemiol (2004) 1.88

The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol (2007) 1.87

Association of body mass with pulmonary function in the Childhood Asthma Management Program (CAMP). Thorax (2003) 1.86

The association between obesity and asthma: interactions between systemic and airway inflammation. Am J Respir Crit Care Med (2008) 1.78

Body mass and glucocorticoid response in asthma. Am J Respir Crit Care Med (2008) 1.68

Obesity and asthma: lessons from animal models. J Appl Physiol (1985) (2006) 1.59

Obesity and asthma: a specific phenotype? Chest (2008) 1.47

Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma. Am J Respir Crit Care Med (2006) 1.46

Effect of nasal continuous positive airway pressure in uncontrolled nocturnal asthmatic patients with obstructive sleep apnea syndrome. Respir Med (2004) 1.41

Body mass index, change in body silhouette, and risk of asthma in the E3N cohort study. Am J Epidemiol (2003) 1.38

Altered respiratory physiology in obesity. Can Respir J (2006) 1.35

Weight loss and asthma: a systematic review. Thorax (2008) 1.29

Obesity and the lung: 4. Obesity and asthma. Thorax (2008) 1.28

Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med (2007) 1.28

Nocturnal asthma: role of snoring and obstructive sleep apnea. Am Rev Respir Dis (1988) 1.23

Body mass index and asthma incidence among USA adults. Eur Respir J (2004) 1.22

Nocturnal asthma: snoring, small pharynx and nasal CPAP. Eur Respir J (1988) 1.05

Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research and Education Network. J Allergy Clin Immunol (2006) 1.02

Obesity and pulmonary function testing. J Allergy Clin Immunol (2005) 0.93

Quality control within the Asthma Clinical Research Network. Control Clin Trials (2001) 0.92

Articles by these authors

Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med (2005) 7.61

Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med (2010) 6.19

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet (2004) 5.01

Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med (2009) 4.83

Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol (2010) 4.38

Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial. JAMA (2012) 4.30

Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol (2006) 3.04

Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med (2007) 2.81

Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol (2010) 2.74

Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006. Anesth Analg (2010) 2.48

beta-Adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med (2005) 2.45

Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States. Anesth Analg (2014) 2.19

Asthma medications should be available for over-the-counter use: pro. Ann Am Thorac Soc (2014) 2.02

Bronchial thermoplasty: ready for prime time--the evidence is there! Chest (2015) 2.01

Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci Transl Med (2013) 2.01

Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. J Allergy Clin Immunol (2005) 1.88

The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol (2007) 1.87

A silent response to the obesity epidemic: decline in US physician weight counseling. Med Care (2013) 1.81

Exhaled breath condensate eicosanoid levels associate with asthma and its severity. J Allergy Clin Immunol (2013) 1.59

Asthma therapies and Churg-Strauss syndrome. J Allergy Clin Immunol (2002) 1.51

Loss of salmeterol bronchoprotection against exercise in relation to ADRB2 Arg16Gly polymorphism and exhaled nitric oxide. Am J Respir Crit Care Med (2013) 1.48

Trombone player's lung: a probable new cause of hypersensitivity pneumonitis. Chest (2010) 1.48

Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma. Am J Respir Crit Care Med (2006) 1.46

Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthma. Am J Respir Crit Care Med (2014) 1.44

A trial of clarithromycin for the treatment of suboptimally controlled asthma. J Allergy Clin Immunol (2010) 1.39

Rebuttal Comments from Dr. Dunn and Dr. Wechsler. Allergy Asthma Proc (2015) 1.37

Do "placebo responders" exist? Contemp Clin Trials (2008) 1.35

Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome. J Allergy Clin Immunol (2010) 1.27

Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma. Int Arch Allergy Immunol (2001) 1.18

Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD). J Allergy Clin Immunol (2012) 1.12

Aeroallergen sensitization correlates with PC(20) and exhaled nitric oxide in subjects with mild-to-moderate asthma. J Allergy Clin Immunol (2008) 1.10

Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine. Am J Health Syst Pharm (2007) 1.07

Effects of stabilizing or increasing respiratory motor outputs on obstructive sleep apnea. J Appl Physiol (1985) (2013) 1.03

Using positive deviance for determining successful weight-control practices. Qual Health Res (2010) 1.02

Minimum ten-year results of primary bipolar hip arthroplasty for degenerative arthritis of the hip. J Bone Joint Surg Am (2006) 1.00

The impact of obesity on sepsis mortality: a retrospective review. BMC Infect Dis (2013) 1.00

Role of central/peripheral chemoreceptors and their interdependence in the pathophysiology of sleep apnea. Adv Exp Med Biol (2012) 0.99

Reducing asthma attacks in patients with severe asthma: The role of bronchial thermoplasty. Allergy Asthma Proc (2015) 0.98

The Mark Coventry Award: Prevention of readmission for venous thromboembolism after total knee arthroplasty. Clin Orthop Relat Res (2006) 0.98

Objective measures of disordered sleep in fibromyalgia. J Rheumatol (2009) 0.94

Sleep quality and asthma control and quality of life in non-severe and severe asthma. Sleep Breath (2011) 0.94

Association of a missense mutation in the NOS3 gene with exhaled nitric oxide levels. Am J Respir Crit Care Med (2003) 0.93

The effect of topical nasal fluticasone on objective sleep testing and the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. Allergy Asthma Proc (2003) 0.93

The heterogeneity of obstructive sleep apnea (predominant obstructive vs pure obstructive apnea). Sleep (2011) 0.93

Preventable newborn readmissions since passage of the Newborns' and Mothers' Health Protection Act. Pediatrics (2006) 0.91

Cardiac arrests and deaths associated with malignant hyperthermia in north america from 1987 to 2006: a report from the north american malignant hyperthermia registry of the malignant hyperthermia association of the United States. Anesthesiology (2008) 0.90

Symposium on obesity and asthma - November 2, 2006. Can Respir J (2007) 0.89

Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective. J Rheumatol (2005) 0.89

Sleep medicine content of major medical textbooks continues to be underrepresented. Sleep Med (2007) 0.86

Effects of chronic intermittent hypoxia on allergen-induced airway inflammation in rats. Am J Respir Cell Mol Biol (2015) 0.86

Pseudoenhancement of renal cysts: influence of lesion size, lesion location, slice thickness, and number of MDCT detectors. AJR Am J Roentgenol (2012) 0.86

Efficacy of a weight-loss website based on positive deviance. A randomized trial. Am J Prev Med (2011) 0.86

The role of pharmacogenomics in improving the management of asthma. J Allergy Clin Immunol (2010) 0.85

Computerized tailored physical activity reports. A randomized controlled trial. Am J Prev Med (2010) 0.85

The John Charnley Award: prevention of readmission for venous thromboembolic disease after total hip arthroplasty. Clin Orthop Relat Res (2005) 0.84

Integrating the overlap of obstructive lung disease and obstructive sleep apnoea: OLDOSA syndrome. Respirology (2013) 0.82

Effects of a web-based patient activation intervention to overcome clinical inertia on blood pressure control: cluster randomized controlled trial. J Med Internet Res (2013) 0.82

Administrative databases: are they useful for clinical analyses? Anesthesiology (2009) 0.82

Conversion from delayed-release sodium valproate to extended-release sodium valproate: initial results and long-term follow-up. Epilepsy Behav (2006) 0.82

Maternal tobacco use and shorter newborn nursery stays. Am J Prev Med (2009) 0.81

P2X7-regulated protection from exacerbations and loss of control is independent of asthma maintenance therapy. Am J Respir Crit Care Med (2012) 0.81

Associations between air pollution and peak expiratory flow among patients with persistent asthma. J Toxicol Environ Health A (2009) 0.80

Predictors of response to tiotropium versus salmeterol in asthmatic adults. J Allergy Clin Immunol (2013) 0.80

Inhibiting interleukin-4 and interleukin-13 in difficult-to-control asthma. N Engl J Med (2013) 0.79

Non-invasive ventilation and gastrostomy may not impact overall quality of life in patients with ALS. Amyotroph Lateral Scler (2012) 0.78

Effects of tobacco dose and length of exposure on delayed neurological deterioration and overall clinical outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery (2007) 0.78

Identification of patients with Churg-Strauss syndrome (CSS) using automated data. Pharmacoepidemiol Drug Saf (2004) 0.78

The role of montelukast on perennial allergic rhinitis and associated sleep disturbances and daytime somnolence. Allergy Asthma Proc (2008) 0.78

beta-adrenergic receptor genotype and response to salmeterol. J Allergy Clin Immunol (2007) 0.78

Novel targeted therapies for eosinophil-associated diseases and allergy. Annu Rev Pharmacol Toxicol (2014) 0.78

Differences between students in problem-based and lecture-based curricula measured by clerkship performance ratings at the beginning of the third year. Teach Learn Med (2002) 0.78

Interaction of ambient air pollution with asthma medication on exhaled nitric oxide among asthmatics. Arch Environ Occup Health (2009) 0.78

Factors associated with systemic hypertension in asthma. Lung (2014) 0.77

Perinatal disparities for black mothers and their newborns. Matern Child Health J (2007) 0.77

Asthma drug use and the development of Churg-Strauss syndrome (CSS). Pharmacoepidemiol Drug Saf (2007) 0.77

The effects of an insertion in the 5'UTR of the AMCase on gene expression and pulmonary functions. Respir Med (2011) 0.77

Colorectal cancer screening in high-risk groups is increasing, although current smokers fall behind. Cancer (2014) 0.76

Asthma pharmacogenetics: responding to the call for a personalized approach. Curr Opin Allergy Clin Immunol (2013) 0.76

Incidence of venous thromboembolism in otolaryngology-head and neck surgery. JAMA Otolaryngol Head Neck Surg (2013) 0.76

Combating the eosinophil with anti-interleukin-5 therapy. N Engl J Med (2008) 0.76

The placebo effect in asthma. Curr Allergy Asthma Rep (2014) 0.76

Effect of topical nasal corticosteroids on patients with chronic fatigue syndrome and rhinitis. J Am Osteopath Assoc (2003) 0.76

Tired and sick. Sleep (2012) 0.75

Influence of Fever and hospital-acquired infection on the incidence of delayed neurological deficit and poor outcome after aneurysmal subarachnoid hemorrhage. Neurol Res Int (2012) 0.75

Reply: safety of short-acting β-agonists not a barrier to making asthma rescue and controller medications available over the counter. Ann Am Thorac Soc (2014) 0.75

Cysteinyl leukotriene antagonism inhibits bronchoconstriction in response to hypertonic saline inhalation in asthma. Respir Med (2010) 0.75

Recommendations for the use of bronchial thermoplasty in the management of severe asthma. S Afr Med J (2015) 0.75

Discussing the COSTS of asthma: controlling outcomes, symptoms, and treatment strategies. Am J Manag Care (2005) 0.75

Does trainee involvement affect anticipatory guidance in well-child care? Clin Pediatr (Phila) (2013) 0.75

Vasopressin for vasopressor-dependent septic shock. Am J Health Syst Pharm (2005) 0.75

Novel Treatments for Airway Disease. N Engl J Med (2017) 0.75

Using the high-dose corticotropin test to diagnose relative adrenal insufficiency in vasopressor-dependent septic shock. Am J Health Syst Pharm (2006) 0.75